Almost one-third of new drugs approved by U.S. regulators over a
decade ended up years later with warnings about unexpected — sometimes
life-threatening — side effects or complications, according to a new
analysis in the Journal of the American Medical Assn.
Researchers looked at potential problems that cropped up during the
routine monitoring that’s done once a medicine has been approved by the
Food and Drug Administration and is on the market. The results,
published Tuesday, covered all 222 prescription drugs approved by the
FDA from 2001 through 2010.
The 71 drugs that were flagged included top sellers for treating
depression, arthritis, infections and blood clots. Safety issues
included risks for serious skin reactions, liver damage, cancer and even
“The large percentage of problems was a surprise,” and they
included side effects not seen during the review process, said senior
author Dr. Joseph Ross, an associate professor of medicine and public
health at Yale University.
They don't call it PRACTICING for nothing...